Loading...

World-Class Retina Care. Community-Based Caring.

New Clinical Trials Available

Posted On May 12, 2023 / By / Posted in Blog

New Clinical Trials Available

At Texas Retina Associates, our physicians remain actively involved in conducting research that will improve care for our patients, offering access to promising new retinal treatments through clinical trials. We recently opened

read more
Posted On February 28, 2023 / By / Posted in Blog

Four New Clinical Trials Available at Texas Retina Associates

Our physicians remain committed to participating in ongoing retina research and providing our patients access to promising new treatment options through clinical trials. We recently opened four new clinical trials: Diabetic Macular

read more
Posted On February 21, 2023 / By / Posted in Blog

FDA Approves First Treatment for Geographic Atrophy

On February 17, 2023, the U.S. Food and Drug Administration (FDA) approved intravitreal pegcetacoplan (brand name Syfovre), the first-ever treatment for geographic atrophy (GA) secondary to age-related macular degeneration (AMD). Texas Retina

read more
Posted On August 8, 2022 / By / Posted in Blog

Texas Retina Associates First in the Country to Dose a Patient in the DAVIO 2 Clinical Trial

Texas Retina Associates is honored to have randomized the first patient in EyePoint Pharmaceuticals’ Phase 2 “Durasert and Vorolanib in Ophthalmology 2” (DAVIO 2) clinical trial of EYP-1901 for patients with wet macular

read more
Posted On June 20, 2022 / By / Posted in Blog

Texas Retina Associates Announces the Retirement of David Callanan, MD

It is with mixed emotions that we announce the retirement of David Callanan, MD, from Texas Retina Associates effective June 30, 2022. He has been caring for patients at our practice since

read more
Posted On April 4, 2022 / By / Posted in Blog

Meet Our Dallas Clinical Research Coordinators

Karen Duignan, Sally Arceneaux, Ashley Hughes and Jessica Flores serve as our clinical research coordinators for Dallas. They assist patients with their enrollment and participation in our wide variety of clinical trials

read more
Posted On November 15, 2021 / By / Posted in Blog

Dr. Abbey Discusses COED Clinical Trial for Diabetic Macular Edema in New Video

In a new video published on Modern Retina, Texas Retina Associates’ Ashkan M. Abbey, MD, discusses the COED clinical trial which is testing the efficacy of combining steroid and anti-VEGF therapy in

read more
Posted On April 6, 2021 / By / Posted in Blog

New Clinical Trials Available

Medical researchers continue to discover new sight-saving treatments for retinal diseases that once robbed patients of their vision. At Texas Retina Associates, we are currently participating in more than 20 clinical trials

read more